IDF Diabetes Atlas | Tenth Edition

Có thể bạn quan tâm

Skip to main content Download 2025 Report Donate

EN
- ES
- FR

Search the site IDF website IDF Atlas Logo

Data by location
- Global
- Africa
- Europe
- Middle-East and North Africa
- North America and Caribbean
- South and Central America
- South-East Asia
- Western Pacific
Data by indicators
- Demographics
  - Total adult population (20-79 y), in 1,000s
  - Population of children and adolescents (0-19 y)
- Diabetes estimates (20-79 y)
  - People with diabetes, in 1,000s
  - Age-standardised prevalence of diabetes, %
  - People with undiagnosed diabetes, in 1,000s
  - Proportion of people with undiagnosed diabetes, %
- Mortality attributable to diabetes (20-79 y)
  - Deaths attributable to diabetes
  - Proportion of diabetes-related deaths in people 20-79 y, %
- Diabetes-related health expenditure
  - Total diabetes-related health expenditure, USD million
  - Total diabetes-related health expenditure, ID million
  - Diabetes-related health expenditure per person, USD
  - Diabetes-related health expenditure per person, ID
- Impaired glucose tolerance (IGT) estimates (20-79 y)
  - People with IGT, in 1,000s
  - Age-standardised prevalence of IGT, %
- Impaired fasting glucose (IFG) estimates (20-79 y)
  - People with IFG, in 1,000s
  - Age-standardised prevalence of IFG, %
- Hyperglycaemia in pregnancy (HIP) (20-49 y)
  - Prevalence of gestational diabetes mellitus (GDM), %
- Type 1 diabetes estimates
  - People with type 1 diabetes (all age groups)
  - People with type 1 diabetes (0-19 y)
Resources
- IDF Diabetes Atlas 2025
- Fact sheets
- Atlas presentation
- Selected studies
- Citation usage
- Reference/reproduction requests
- Podcasts
- Scientific papers and posters
- Previous editions
- IDF Diabetes Atlas Reports
- IDF Guide for Epidemiology Studies
FAQs
Committee
Contact

Data by location
- Global
- Africa
- Europe
- Middle-East and North Africa
- North America and Caribbean
- South and Central America
- South-East Asia
- Western Pacific
Data by indicators
- Demographics
  - Total adult population (20-79 y), in 1,000s
  - Population of children and adolescents (0-19 y)
- Diabetes estimates (20-79 y)
  - People with diabetes, in 1,000s
  - Age-standardised prevalence of diabetes, %
  - People with undiagnosed diabetes, in 1,000s
  - Proportion of people with undiagnosed diabetes, %
- Mortality attributable to diabetes (20-79 y)
  - Deaths attributable to diabetes
  - Proportion of diabetes-related deaths in people 20-79 y, %
- Diabetes-related health expenditure
  - Total diabetes-related health expenditure, USD million
  - Total diabetes-related health expenditure, ID million
  - Diabetes-related health expenditure per person, USD
  - Diabetes-related health expenditure per person, ID
- Impaired glucose tolerance (IGT) estimates (20-79 y)
  - People with IGT, in 1,000s
  - Age-standardised prevalence of IGT, %
- Impaired fasting glucose (IFG) estimates (20-79 y)
  - People with IFG, in 1,000s
  - Age-standardised prevalence of IFG, %
- Hyperglycaemia in pregnancy (HIP) (20-49 y)
  - Prevalence of gestational diabetes mellitus (GDM), %
- Type 1 diabetes estimates
  - People with type 1 diabetes (all age groups)
  - People with type 1 diabetes (0-19 y)
Resources
- IDF Diabetes Atlas 2025
- Fact sheets
- Atlas presentation
- Selected studies
- Citation usage
- Reference/reproduction requests
- Podcasts
- Scientific papers and posters
- Previous editions
- IDF Diabetes Atlas Reports
- IDF Guide for Epidemiology Studies
FAQs
Committee
Contact